Benedito Arruda Carneiro (Benedito A Carneiro, Benedito A Carnero)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Acute Myeloid Leukemia

Stem Cell Transplantation

Top Venues

Medicina (Kaunas, Lithuania)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew J Hadfield, Howard Safran, Marco A Purbhoo, Joseph E Grossman, Jennifer S Buell, Benedito Arruda Carneiro
Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT). Oncogene 43 (10) (2024)
Matthew J Hadfield, Howard Safran, Marco A Purbhoo, Joseph E Grossman, Jennifer S Buell, Benedito Arruda Carneiro
Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT). Oncogene (2024)
Matthew J Hadfield, Howard Safran, Marco A Purbhoo, Joseph E Grossman, Jennifer S Buell, Benedito Arruda Carneiro
Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT). Oncogene 43 (10) (2024)
Matthew J Hadfield, Howard Safran, Marco A Purbhoo, Joseph E Grossman, Jennifer S Buell, Benedito Arruda Carneiro
Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT). Oncogene 43 (10) (2024)
Matthew J Hadfield, Howard Safran, Marco A Purbhoo, Joseph E Grossman, Jennifer S Buell, Benedito Arruda Carneiro
Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT). Oncogene 43 (10) (2024)
Ezra Y Rosen, Timothy Anthony Yap, Elizabeth K Lee, Martin Højgaard, Niharika B Mettu, Stéphanie Lheureux, Benedito Arruda Carneiro, Ruth Plummer, Adrian J Fretland, Danielle Ulanet, Yi Xu, Robin McDougall, Maria Koehler, Elisa Fontana
Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related (ATR) Inhibitor Camonsertib. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, Christoph Schorl, Shaolei Lu, David L Silverberg, Daniel Newhouse, Zhijin Wu, Lanlan Zhou, Brittany A Borden, Francis J Giles, Mark Dooner, Benedito Arruda Carneiro, Wafik S El-Deiry
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. International journal of molecular sciences 24 (13) (2023)
Justin H Hwang, Xiaolei Shi, Andrew Elliott, Taylor E Arnoff, Julie E McGrath, Joanne Xiu, Phillip Walker, Hannah E Bergom, Abderrahman Day, Shihab Ahmed, Sydney Tape, Allison Makovec, Atef Ali, Rami M Shaker, Eamon Toye, Rachel Passow, John R Lozada, Jinhua Wang, Emil Lou, Kent W Mouw, Benedito Arruda Carneiro, Elisabeth I Heath, Rana R McKay, Wolfgang Michael Korn, Chadi Nabhan, Charles J Ryan, Emmanuel S Antonarakis
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Stephen K Tahir, Emiliano Calvo, Benedito Arruda Carneiro, Junichiro Yuda, Aditya V Shreenivas, Mojca Jongen-Lavrencic, Eelke H Gort, Kenichi Ishizawa, Daniel Morillo, Carla Biesdorf, Morey Smith, Dong Cheng, Monica Motwani, David Sharon, Tamar Uziel, Dimple A Modi, Fritz G Buchanan, Susan Morgan-Lappe, Bruno C Medeiros, Darren C Phillips
Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia. Blood (2023)
Stephen K Tahir, Emiliano Calvo, Benedito Arruda Carneiro, Junichiro Yuda, Aditya V Shreenivas, Mojca Jongen-Lavrencic, Eelke H Gort, Kenichi Ishizawa, Daniel Morillo, Carla Biesdorf, Morey Smith, Dong Cheng, Monica Motwani, David Sharon, Tamar Uziel, Dimple A Modi, Fritz G Buchanan, Susan Morgan-Lappe, Bruno C Medeiros, Darren C Phillips
Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia. Blood (2023)
Benedito Arruda Carneiro, Ludimila Cavalcante, Devalingam Mahalingam, Anwaar Saeed, Howard Safran, Wen Wee Ma, Andrew L Coveler, Steven Francis Powell, Bruno R Bastos, Elizabeth J Davis, Vaibhav Sahai, William Mikrut, James Longstreth, Sheri Smith, Taylor M Weiskittel, Hu Li, Brittany A Borden, Robert Donald Harvey, Solmaz Sahebjam, Andres Cervantes, Austin Koukol, Andrew P Mazar, Neeltje Steeghs, Razelle Kurzrock, Francis J Giles, Pamela N Munster
Phase 1 study of Elraglusib (9-ING-41), a glycogen synthase kinase-3b inhibitor, as monotherapy or combined with chemotherapy in patients with advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Andrew Hsu, Kelsey E Huntington, Andre De Souza, Lanlan Zhou, Adam J Olszewski, Nirav P Makwana, Diana O Treaba, Ludimila Cavalcante, Francis J Giles, Howard Safran, Wafik S El-Deiry, Benedito Arruda Carneiro
Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma. Cancer biology & therapy 23 (1) (2022)
Sourat Darabi, David R Braxton, Joanne Xiu, Benedito Arruda Carneiro, Jeff Swensen, Emmanuel S Antonarakis, Stephen V Liu, Rana R McKay, David Spetzler, Wafik S El-Deiry, Michael J Demeure
BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents. Medicina (Kaunas, Lithuania) 58 (12) (2022)
Sourat Darabi, David R Braxton, Joanne Xiu, Benedito Arruda Carneiro, Jeff Swensen, Emmanuel S Antonarakis, Stephen V Liu, Rana R McKay, David Spetzler, Wafik S El-Deiry, Michael J Demeure
BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents. Medicina (Kaunas, Lithuania) 58 (12) (2022)
Sourat Darabi, David R Braxton, Joanne Xiu, Benedito Arruda Carneiro, Jeff Swensen, Emmanuel S Antonarakis, Stephen V Liu, Rana R McKay, David Spetzler, Wafik S El-Deiry, Michael J Demeure
BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents. Medicina (Kaunas, Lithuania) 58 (12) (2022)
Benedito Arruda Carneiro, Kyriakos P Papadopoulos, John H Strickler, Andrew B Lassman, Saiama N Waqar, Young Kwang Chae, Jyoti D Patel, Einat Shacham-Shmueli, Karen Kelly, Mustafa Khasraw, Christine M Bestvina, Ryan Merrell, Kevin Huang, Harisha Atluri, Peter Ansell, Rachel Li, Janet Jin, Mark G Anderson, Edward B Reilly, Gladys Morrison-Thiele, Kalpesh Patel, Randy R Robinson, Martha R Neagu Aristide, Hui K Gan
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma. Neuro-oncology advances 5 (1) (2022)
Sourat Darabi, David R Braxton, Joanne Xiu, Benedito Arruda Carneiro, Jeff Swensen, Emmanuel S Antonarakis, Stephen V Liu, Rana R McKay, David Spetzler, Wafik S El-Deiry, Michael J Demeure
BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents. Medicina (Kaunas, Lithuania) 58 (12) (2022)
Sourat Darabi, David R Braxton, Joanne Xiu, Benedito Arruda Carneiro, Jeff Swensen, Emmanuel S Antonarakis, Stephen V Liu, Rana R McKay, David Spetzler, Wafik S El-Deiry, Michael J Demeure
BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents. Medicina (Kaunas, Lithuania) 58 (12) (2022)
Benedito Arruda Carneiro, Kyriakos P Papadopoulos, John H Strickler, Andrew B Lassman, Saiama N Waqar, Young Kwang Chae, Jyoti D Patel, Einat Shacham-Shmueli, Karen Kelly, Mustafa Khasraw, Christine M Bestvina, Ryan Merrell, Kevin Huang, Harisha Atluri, Peter Ansell, Rachel Li, Janet Jin, Mark G Anderson, Edward B Reilly, Gladys Morrison-Thiele, Kalpesh Patel, Randy R Robinson, Martha R Neagu Aristide, Hui K Gan
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma. Neuro-oncology advances 5 (1) (2022)
Ana Claudia da Silva Mendes de Oliveira, Antonio Vinicios Alves da Silva, Marclesson Alves, Eduardo Henrique Cronemberger, Benedito Arruda Carneiro, Juliana Carneiro Melo, Francisco Martins Neto, Fabio Rocha Fernandes Tavora
Molecular profile of non-small cell lung cancer in northeastern Brazil. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 45 (3) (2019)